MYOVANT SCIENCES LTD's ticker is MYOV and the CUSIP is G637AM102. A total of 66 filers reported holding MYOVANT SCIENCES LTD in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $163,054 | -56.1% | 6,048 | -70.8% | 0.00% | – |
| Q3 2022 | $371,000 | +30.2% | 20,685 | -9.9% | 0.00% | – |
| Q2 2022 | $285,000 | -14.9% | 22,948 | -8.8% | 0.00% | – |
| Q1 2022 | $335,000 | -19.7% | 25,152 | -6.0% | 0.00% | – |
| Q4 2021 | $417,000 | -36.2% | 26,771 | -8.2% | 0.00% | – |
| Q3 2021 | $654,000 | -5.8% | 29,166 | -4.3% | 0.00% | – |
| Q2 2021 | $694,000 | +8.6% | 30,484 | -1.8% | 0.00% | – |
| Q1 2021 | $639,000 | -2.0% | 31,051 | +31.5% | 0.00% | – |
| Q4 2020 | $652,000 | +222.8% | 23,611 | +64.2% | 0.00% | – |
| Q3 2020 | $202,000 | -60.6% | 14,380 | -42.2% | 0.00% | – |
| Q2 2020 | $513,000 | +701.6% | 24,887 | +191.8% | 0.00% | – |
| Q1 2020 | $64,000 | -34.7% | 8,530 | +34.8% | 0.00% | – |
| Q4 2019 | $98,000 | +4800.0% | 6,330 | +2010.0% | 0.00% | – |
| Q3 2019 | $2,000 | -98.3% | 300 | -97.8% | 0.00% | – |
| Q2 2019 | $121,000 | -76.5% | 13,340 | -38.2% | 0.00% | – |
| Q1 2019 | $515,000 | +39.9% | 21,596 | -3.8% | 0.00% | – |
| Q4 2018 | $368,000 | +89.7% | 22,440 | +35.8% | 0.00% | – |
| Q1 2017 | $194,000 | +304.2% | 16,527 | +331.9% | 0.00% | – |
| Q4 2016 | $48,000 | – | 3,827 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| VitalStone Financial, LLC | 15 | $0 | 0.00% |
| HUNTINGTON NATIONAL BANK | 1 | $27 | 0.00% |